Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael Lawrence Dougan, M.D.,Ph.D.


This page shows the publications co-authored by Michael Dougan and Yousef Badran.
Connection Strength

  1. Immune-related adverse events: what we've learned and where we're heading. Expert Rev Anticancer Ther. 2020 09; 20(9):727-730.
    View in: PubMed
    Score: 0.916
  2. Immune checkpoint inhibitor-associated celiac disease. J Immunother Cancer. 2020 06; 8(1).
    View in: PubMed
    Score: 0.900
  3. Concurrent therapy with immune checkpoint inhibitors and TNFa blockade in patients with gastrointestinal immune-related adverse events. J Immunother Cancer. 2019 08 22; 7(1):226.
    View in: PubMed
    Score: 0.853
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.